Mechanisms of resistance to quinolones

GA Jacoby - Clinical infectious diseases, 2005 - academic.oup.com
The increased use of fluoroquinolones has led to increasing resistance to these
antimicrobials, with rates of resistance that vary by both organism and geographic region …

Mutant selection window hypothesis updated

K Drlica, X Zhao - Clinical infectious diseases, 2007 - academic.oup.com
The mutant selection window hypothesis postulates that, for each antimicrobial-pathogen
combination, an antimicrobial concentration range exists in which selective amplification of …

Fluoroquinolone antimicrobial agents

JS Wolfson, DC Hooper - Clinical microbiology reviews, 1989 - Am Soc Microbiol
The fluoroquinolones, a new class of potent orally absorbed antimicrobial agents, are
reviewed, considering structure, mechanisms of action and resistance, spectrum, variables …

Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions

M LeBel - … : The Journal of Human Pharmacology and Drug …, 1988 - Wiley Online Library
Ciprofloxacin, considered a benchmark when comparing new fluoroquinolones, shares with
these agents a common mechanism of action: inhibition of DNA gyrase. While ciprofloxacin …

Immunomodulatory effects of quinolones

A Dalhoff, I Shalit - The Lancet infectious diseases, 2003 - thelancet.com
We review data on the in-vitro, ex-vivo, in-vivo, and clinical effects of fluoroquinolones on the
synthesis of cytokines and their mechanisms of immunomodulation. In general, most …

[PDF][PDF] The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

DC Hooper, JS Wolfson - Antimicrobial agents and chemotherapy, 1985 - Am Soc Microbiol
HUMAN PHARMACOLOGY OF THE FLUOROQUINOLONES The pharmacologic properties
of the fluoroquinolones have in general been determined in healthy human volun-teers …

Clinical pharmacokinetics of ciprofloxacin

K Vance-Bryan, DRP Guay, JC Rotschafer - Clinical pharmacokinetics, 1990 - Springer
Compared with nalidixic acid, ciprofloxacin is representative of a newer, more potent class of
quinolones, termed the fluoroquinolones. It is available in both oral and parenteral dosage …

Analysis of fluoroquinolones in biological fluids by high-performance liquid chromatography

G Carlucci - Journal of Chromatography A, 1998 - Elsevier
High-performance liquid chromatographic methods for the analysis of fluoroquinolones in
biological fluids are reviewed. In particular, sample preparation and handling procedures …

Fluoroquinolone antibiotics: microbiology, pharmacokinetics and clinical use

JH Paton, DS Reeves - Drugs, 1988 - Springer
The newer fluoroquinolones are a major advance in antimicrobial chemotherapy. They
inhibit the supercoiling activity of the DNA gyrase enzyme, thus exerting their antibacterial …

Absolute oral bioavailability of ciprofloxacin

GL Drusano, HC Standiford, K Plaisance… - Antimicrobial agents …, 1986 - Am Soc Microbiol
We evaluated the absolute bioavailability of ciprofloxacin, a new quinoline carboxylic acid,
in 12 healthy male volunteers. Doses of 200 mg were given to each of the volunteers in a …